Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Tiziana Life Sciences Ltd banner

Tiziana Life Sciences Ltd
NASDAQ:TLSA

Watchlist Manager
Tiziana Life Sciences Ltd Logo
Tiziana Life Sciences Ltd
NASDAQ:TLSA
Watchlist
Price: 0.69 USD 2.99%
Market Cap: $88.3m
Write Note Create Alert

Intrinsic Value

Is TLSA undervalued or overvalued?

See the intrinsic value estimate for Tiziana Life Sciences Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

TLSA Intrinsic Value
LOCKED
Unlock
Today vs. history

TLSA looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with TLSA’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor TLSA
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price $0.69
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to TLSA

Fundamental Analysis

What Tiziana Life Sciences Does

Biotechnology Health Care

Tiziana Life Sciences is a clinical-stage biotechnology company that develops experimental medicines for immune and inflammatory diseases. Its main drug candidate is foralumab, an anti-CD3 antibody designed to be given through the nose so it can calm harmful immune activity without the same level of whole-body exposure as a standard injected treatment. The company is also exploring related immune-modulating programs in areas such as multiple sclerosis, neuroinflammation, and other conditions tied to overactive inflammation.

Headquarters
United Kingdom UK
Employees
8
IPO date
Nov 20, 2018
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Tiziana Life Sciences Ltd

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

TLSA Insider Trading
Buy and sell transactions by insiders

Continue TLSA Research

Summary
TLSA intrinsic value, competitors valuation, and company profile.
DCF Valuation
TLSA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TLSA stock valuation using valuation multiples.
Wall St Estimates
TLSA price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TLSA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Tiziana Life Sciences Ltd listings:
F • EUR
0RP
Discover More
What is the Intrinsic Value of one TLSA stock?

The intrinsic value for Tiziana Life Sciences Ltd (TLSA) under the Base Case is hidden USD.

Is TLSA stock undervalued or overvalued?

Compared with the current market price of 0.69 USD, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 363,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.